- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: Nucleotide salvage.
Displaying page 1 of 1.
| EudraCT Number: 2016-003599-39 | Sponsor Protocol Number: SAKK08/15 | Start Date*: 2017-12-13 |
| Sponsor Name:Swiss Group for Clinical Cancer Research (SAKK) | ||
| Full Title: PROMET - Multicenter, Randomized Phase II Trial of Salvage Radiotherapy +/- Metformin for Patients with Prostate Cancer after Prostatectomy | ||
| Medical condition: Histologically confirmed adenocarcinoma of the prostate without small cell features with PSA progression after radical prostatectomy | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male | |
| Trial protocol: DE (Completed) FR (Completed) | ||
| Trial results: View results | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.